Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

229 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pertussis in adults: frequency of transmission after household exposure.
Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt HJ. Wirsing von König CH, et al. Among authors: schmitt hj. Lancet. 1995 Nov 18;346(8986):1326-9. doi: 10.1016/s0140-6736(95)92343-8. Lancet. 1995. PMID: 7475771
Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany.
Tormans G, Van Doorslaer E, van Damme P, Clara R, Schmitt HJ. Tormans G, et al. Among authors: schmitt hj. Eur J Pediatr. 1998 May;157(5):395-401. doi: 10.1007/s004310050837. Eur J Pediatr. 1998. PMID: 9625337
Efficacy of a three-component acellular pertussis vaccine (DTaP) in early childhood after household exposure to "typical" (WHO-defined) pertussis.
Schmitt HJ. Schmitt HJ. Dev Biol Stand. 1997;89:67-9. Dev Biol Stand. 1997. PMID: 9333573 No abstract available.
Safety and efficacy of acellular pertussis vaccines: the Mainz study and other recent studies.
Weigl JA, Bock HL, Clemens R, Zepp F, Habermehl P, Beutel K, Müschenborn S, Sümenicht G, Schuind A, von König CH, Neiss A, Laukamp S, Kiederle S, Schmitt HJ. Weigl JA, et al. Among authors: schmitt hj. Ann Acad Med Singap. 1997 May;26(3):320-5. Ann Acad Med Singap. 1997. PMID: 9285026 Review.
Toxoid vaccine for pertussis.
von König CH, Schmitt HJ. von König CH, et al. Among authors: schmitt hj. Lancet. 1997 Jan 11;349(9045):136; author reply 137-8. doi: 10.1016/s0140-6736(05)60925-7. Lancet. 1997. PMID: 8996450 No abstract available.
Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants.
Schmitt HJ, Schuind A, Knuf M, Beutel K, Schulte-Wissermann H, Gahr M, Schult R, Folkens J, Rauh W, Bogaerts H, Bork HL, Clemens R. Schmitt HJ, et al. J Pediatr. 1996 Nov;129(5):695-701. doi: 10.1016/s0022-3476(96)70152-x. J Pediatr. 1996. PMID: 8917236 Clinical Trial.
Acellular pertussis vaccines: the rationale for an efficacy trial in Germany.
Schmitt HJ, Schuind A, Knuf M, Zepp F, Beutel K, Wirsing von König CH, Neiss A, Bock HL, Bogaerts H, Clemens R. Schmitt HJ, et al. J Infect Dis. 1996 Nov;174 Suppl 3:S287-90. doi: 10.1093/infdis/174.supplement_3.s287. J Infect Dis. 1996. PMID: 8896531 Review.
Epidemiologic aspects and diagnostic criteria for a protective efficacy field trial of a pertussis vaccine.
Wirsing von König CH, Schmitt HJ. Wirsing von König CH, et al. Among authors: schmitt hj. J Infect Dis. 1996 Nov;174 Suppl 3:S281-6. doi: 10.1093/infdis/174.supplement_3.s281. J Infect Dis. 1996. PMID: 8896530
Acellular pertussis vaccines: the final countdown.
Schmitt HJ. Schmitt HJ. Eur J Pediatr. 1996 Feb;155(2):74-6. doi: 10.1007/BF02075753. Eur J Pediatr. 1996. PMID: 8775216 No abstract available.
Symptoms and complications of pertussis in adults.
Postels-Multani S, Schmitt HJ, Wirsing von König CH, Bock HL, Bogaerts H. Postels-Multani S, et al. Among authors: schmitt hj. Infection. 1995 May-Jun;23(3):139-42. doi: 10.1007/BF01793853. Infection. 1995. PMID: 7499001
229 results
Jump to page
Feedback